Patrys Ltd
ASX:PAB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Patrys Ltd
Patrys Ltd
PP&E Net
Patrys Ltd
PP&E Net Peer Comparison
MSB
CSL
CUV
TLX
PYC
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Patrys Ltd
ASX:PAB
|
PP&E Net
AU$3k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-37%
|
|
|
Mesoblast Ltd
ASX:MSB
|
PP&E Net
$5.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
PP&E Net
$9.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
19%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
PP&E Net
AU$7.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
89%
|
CAGR 10-Years
51%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
PP&E Net
AU$30.5m
|
CAGR 3-Years
85%
|
CAGR 5-Years
167%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
PP&E Net
AU$1.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
48%
|
CAGR 10-Years
15%
|
See Also
What is Patrys Ltd's PP&E Net?
PP&E Net
3k
AUD
Based on the financial report for Dec 31, 2023, Patrys Ltd's PP&E Net amounts to 3k AUD.
What is Patrys Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
-37%
Over the last year, the PP&E Net growth was 13%. The average annual PP&E Net growth rates for Patrys Ltd have been -17% over the past three years , -6% over the past five years , and -37% over the past ten years .
You don't have any saved screeners yet
